dpp4i and glp 1 agonist GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? Comparison of GLP-1 receptor agonists
Description
These benefits occur through blood pressure reduction (1-5.4 mmHg lower systolic blood pressure) 10 , improved vascular function, and direct effects on the heart
Nausea can become a cycle: low appetite leads to low intake, low intake leads to weakness or queasiness, and then food feels even harder to tolerate
The recommended SAXENDA daily dose is 3 mg, with a gradual dose escalation starting at 0.6 mg per day and increasing weekly to minimize side effects
The most frequent adverse events are gastrointestinal side effects that are mild to moderate, dose-dependent, and transient during the first weeks of treatment
*Disclaimer: Major Players sorted in no particular order Recent Industry Developments December 2025: WHO recommended GLP-1 receptor agonists as part of comprehensive adult-obesity care, citing cardio-metabolic benefits
